We are live on ! Find out more
FI

Focused Investors Portfolio holdings

AUM $2.96B
1-Year Est. Return 15.6%
This Fund
S&P 500
This Quarter Est. Return
+1.14%
1 Year Est. Return
+15.6%
3 Year Est. Return
+51.26%
5 Year Est. Return
+77.43%
10 Year Est. Return
+309.27%
AUM
$2.28B
AUM Growth
+$1.54M
Cap. Flow
-$4.31M
Cap. Flow %
-0.19%
Top 10 Hldgs %
61.08%
Holding
21
New
1
Increased
–
Reduced
20
Closed
–

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$77.7M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$51.5M
2
ZBH icon
Zimmer Biomet
ZBH
+$21.6M
3
GS icon
Goldman Sachs
GS
+$836K
4
ELV icon
Elevance Health
ELV
+$740K
5
UNH icon
UnitedHealth
UNH
+$676K

Sector Composition

Rank Sector Weight
1 Healthcare 30.02%
2 Financials 24.52%
3 Consumer Staples 16.87%
4 Consumer Discretionary 10.38%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.74T
$159M 6.95%
1,141,300
-4,800
-0.4% -$660K
AXP icon
2
American Express
AXP
$230B
$156M 6.83%
1,318,100
-4,600
-0.3% -$564K
ELV icon
3
Elevance Health
ELV
$84.7B
$153M 6.7%
636,700
-2,700
-0.4% -$740K
JNJ icon
4
Johnson & Johnson
JNJ
$626B
$145M 6.33%
1,116,900
-5,100
-0.5% -$672K
MCD icon
5
McDonald's
MCD
$194B
$141M 6.16%
654,700
-2,500
-0.4% -$536K
TGT icon
6
Target
TGT
$69.2B
$140M 6.15%
1,312,100
-5,500
-0.4% -$523K
UNH icon
7
UnitedHealth
UNH
$361B
$136M 5.95%
625,100
-2,800
-0.4% -$676K
RTX icon
8
RTX Corp
RTX
$302B
$127M 5.58%
1,481,901
-6,515
-0.4% -$541K
ZBH icon
9
Zimmer Biomet
ZBH
$18.5B
$126M 5.5%
942,244
-167,375
-15% -$21.6M
PEP icon
10
PepsiCo
PEP
$189B
$112M 4.92%
819,500
-3,500
-0.4% -$465K
JPM icon
11
JPMorgan Chase
JPM
$962B
$110M 4.82%
933,900
-2,700
-0.3% -$305K
BAC icon
12
Bank of America
BAC
$448B
$108M 4.72%
3,692,000
-14,200
-0.4% -$408K
HD icon
13
Home Depot
HD
$353B
$96.4M 4.22%
415,500
-2,000
-0.5% -$437K
MS icon
14
Morgan Stanley
MS
$338B
$95.8M 4.2%
2,244,400
-6,900
-0.3% -$295K
GS icon
15
Goldman Sachs
GS
$301B
$90.4M 3.96%
436,000
-4,000
-0.9% -$836K
KO icon
16
Coca-Cola
KO
$372B
$81.4M 3.57%
1,495,000
-6,300
-0.4% -$337K
PARA
17
DELISTED
Paramount Global Class B
PARA
$73.2M 3.21%
1,813,500
-7,800
-0.4% -$365K
CI icon
18
Cigna
CI
$72.4B
$72.4M 3.17%
+477,300
New +$77.7M
FDX icon
19
FedEx
FDX
$76.3B
$56.1M 2.46%
385,500
-1,600
-0.4% -$258K
CVS icon
20
CVS Health
CVS
$120B
$53.8M 2.36%
852,400
-869,072
-50% -$51.5M
DEO icon
21
Diageo
DEO
$52.8B
$51M 2.24%
311,900
-1,500
-0.5% -$251K

Similar funds

SSM
Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return
VGM
Voyager Global Management New York $2.94B AUM 9.74% 1-Year Est. Return
CSIC
Clifford Swan Investment Counsel Pasadena, California $2.94B AUM 21.31% 1-Year Est. Return
BCF
BLS Capital Fondsmaeglerselskab Klampenborg, Denmark $2.94B AUM 13.53% 1-Year Est. Return
PHAM
Pacific Heights Asset Management San Francisco, California $2.99B AUM 52.5% 1-Year Est. Return
SP
SurgoCap Partners New York $2.99B AUM 39.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NC
NZS Capital Denver, Colorado $3B AUM 21.29% 1-Year Est. Return

Focused Investors's Q3 2019 Portfolio in Review

As of Q3 2019, Focused Investors held 21 positions worth $2.28B, up 0.07% from $2.28B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.8%. Focused Investors opened 1 new position and made no exits, leaving the 21-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Staples.

  • Focused Investors's largest Q3 2019 buy was Cigna: 477,300 shares worth $72.4M.
  • Focused Investors's biggest Q3 2019 reduction was CVS Health, cutting an estimated $51.5M.
  • Focused Investors's ten largest holdings make up 61% of its $2.28B portfolio in Q3 2019.
  • Focused Investors opened 1 new position and closed 0 in Q3 2019.
  • Focused Investors's portfolio value rose 0.07% quarter-over-quarter to $2.28B.

Based on Focused Investors's 13F filing for Q3 2019, filed 21 Oct 2019.